Guidelines for the management of actinic keratoses.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  EJD. European journal of dermatology

• Publication date

  2006-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1684/EJD.2006.0017PMID 17229598
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Use of Ex Vivo Confocal Scanning Laser Microscopy during Mohs Surgery for Nonmelanoma Skin Cancers

  2004cited by this paper
• Human Papillomaviruses in Transplant‐Associated Skin Cancers

  2004cited by this paper
• Full face laser resurfacing: Therapy and prophylaxis for actinic keratoses and non‐melanoma skin cancer

  2004cited by this paper
• Low incidence of new actinic keratoses after topical 5% imiquimod cream treatment: a long-term follow-up study.

  2004cited by this paper
• Actinic keratoses--surgical and physical therapeutic modalities.

  2003cited by this paper
• IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis.

  2003cited by this paper
• Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial.

  2003cited by this paper
• Solar keratosis is squamous cell carcinoma.

  2003cited by this paper
• Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization.

  2003cited by this paper
• A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.

  2003cited by this paper
• The use of topical fluorouracil to treat actinic keratosis.

  2002cited by this paper
• Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway

  2002cited by this paper
• Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.

  2002cited by this paper
• Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group

  2002cited by this paper
• [Skin diseases in organ transplant patients].

  2002cited by this paper
• Acitretin for prophylaxis of cutaneous malignancies after cardiac transplantation.

  2002cited by this paper
• Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: A prospective, randomized study.

  2002cited by this paper
• Human papillomaviruses and non-melanoma skin cancer

  2002cited by this paper
• Topical treatment of actinic keratoses with 3·0% diclofenac in 2·5% hyaluronan gel

  2002cited by this paper
• The management of actinic keratoses in the United States with topical fluorouracil: a pharmacoeconomic evaluation.

  2002cited by this paper
• Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment.

  2002cited by this paper
• A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses.

  2002cited by this paper
• Inflammation is associated with progression of actinic keratoses to squamous cell carcinomas in humans

  2002cited by this paper
• [Disseminated actinic keratoses. Comparison of topical photodynamic therapy with 5-aminolevulinic acid and topical 5% imiquimod cream].

  2001cited by this paper
• A comparison of the skin permeation of three topical 0.5% fluorouracil formulations with that of a 5% formulation.

  2001cited by this paper
• The epidemiology of UV induced skin cancer.

  2001cited by this paper
• Retinoid chemoprevention in patients at high risk for skin cancer.

  2001cited by this paper
• Cutaneous Vitamins A and E in the Context of Ultraviolet- or Chemically-Induced Oxidative Stress

  2001cited by this paper
• Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses

  2001cited by this paper
• The nature of solar keratosis: a critical review in historical perspective.

  2000cited by this paper
• E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage

  2000cited by this paper
• High incidence and regression rates of solar keratoses in a queensland community.

  2000cited by this paper
• Actinic Keratosis Is Squamous Cell Carcinoma

  2000cited by this paper
• Prevalence of solar damage and actinic keratosis in a Merseyside population

  2000cited by this paper
• Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins.

  2000cited by this paper
• Cryopeeling (extensive cryosurgery) for treatment of actinic keratoses: an update and comparison.

  2000cited by this paper
• Disappointing results following resurfacing of facial skin with CO2 lasers for prophylaxis of keratoses and cancers.

  1999cited by this paper
• Tolerance of Topical Retinaldehyde in Humans

  1999cited by this paper
• Principles of Cutaneous Cryosurgery: An Update

  1999cited by this paper
• Cutaneous squamous cell carcinomas consistently show histologic evidence of in situ changes: a clinicopathologic correlation.

  1999cited by this paper
• Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil.

  1999cited by this paper
• Imiquimod applied topically: a novel immune response modifier and new class of drug.

  1999cited by this paper
• Does intermittent "pulse" topical 5-fluorouracil therapy allow destruction of actinic keratoses without significant inflammation?

  1998cited by this paper
• The use of modified phenol for chemical face peeling.

  1998cited by this paper
• Frequency of pre‐existing actinic keratosis in cutaneous squamous cell carcinoma

  1998cited by this paper
• Actinic keratoses.

  1997cited by this paper
• Long‐Term Efficacy and Safety of Jessner's Solution and 35% Trichloroacetic Acid vs 5% Fluorouracil in the Treatment of Widespread facial Actinic Keratoses

  1997cited by this paper
• Medium-depth chemical peeling.

  1996cited by this paper
• Dermabrasion for Prophylaxis and Treatment of Actinic Keratoses

  1996cited by this paper
• Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin.

  1996cited by this paper
• A comparison of the efficacy and safety of Jessner's solution and 35% trichloroacetic acid vs 5% fluorouracil in the treatment of widespread facial actinic keratoses.

  1995cited by this paper
• Reduction of solar keratoses by regular sunscreen use.

  1993cited by this paper
• Advances in cryosurgery during the past decade.

  1993cited by this paper
• Shave Excision of Superficial Solar Skin Lesions

  1987cited by this paper
• [Retinoids in the treatment of epithelial skin tumors].

  1986cited by this paper
• Cryosurgery cure rate of actinic keratoses.

  1982cited by this paper
• Etretinate in treatment of actinic keratosis. A double-blind crossover study.

  1982cited by this paper
• Characterization of two types of human papillomaviruses in lesions of epidermodysplasia verruciformis.

  1978cited by this paper

• Clinico-Pathologic Profile of a Cohort of Patients with Actinic Keratosis in a Tertiary Center in Romania

  2025cites this paper
• Self-Applied Daylight Photodynamic Therapy: A Paradigm Shift?

  2025influential citation
• Actinic keratosis: Current challenges and unanswered questions

  2024cites this paper
• Trends in photodynamic therapy for dermatology in recent 20 years: A scientometric review based on CiteSpace

  2023cites this paper
• Efficacy and safety of tirbanibulin 1% ointment in actinic keratoses: Data from two phase‐III trials and the real‐life clinical practice presented at the European Academy of Dermatology and Venereology Congress 2022

  2023cites this paper
• Basal Proliferation and Acantholysis May Represent Histological High-Risk Factors for Progression into Invasive Squamous Cell Carcinoma: A Comparison Study in Solid Organ Transplant Recipients and Matched Immunocompetent Patients

  2023cites this paper
• Assessment of reflectance confocal microscopy for monitoring treatment of actinic keratosis and field cancerization with daylight photodynamic therapy

  2023cites this paper
• Exposome and Skin. Part 2. The Influential Role of the Exposome, Beyond UVR, in Actinic Keratosis, Bowen’s Disease and Squamous Cell Carcinoma: A Proposal

  2022cites this paper
• Insurance Coverage of Dermabrasion and Chemical Peel Procedures: A Critical Analysis of 58 American Insurance Companies

  2022cites this paper
• Topical Pharmacotherapy for Actinic Keratoses in Older Adults

  2022cites this paper
• Topical and Intralesional Chemotherapeutic Agents

  2021cites this paper
• BENEFÍCIOS NA UTILIZAÇÃO DE IMIQUIMODE PARA CÂNCERES DE PELE NÃO MELANOCÍTICOS

  2021cites this paper
• Carcinoma de células escamosas cutâneo em cães

  2021cites this paper
• Relationship between actinic keratosis and malignant skin lesions on the eyelid

  2021cites this paper
• Actinic keratoses contiguous with squamous cell carcinomas are mostly non-hyperkeratotic and with severe dysplasia

  2021cites this paper
• Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients.

  2020cites this paper
• Therapeutic Options for the Treatment of Actinic Keratosis with Scalp and Face Localization.

  2020cites this paper
• Current therapies for actinic keratosis

  2020cites this paper
• Comparison between 5% imiquimod cream and Jessner’s solution with 35% trichloroacetic acid chemical peel in the treatment of the facial field cancerization

  2020cites this paper
• Treatment of cutaneous field cancerization

  2020cites this paper
• Evaluation of diagnostic criteria of actinic keratosis through reflectance confocal microscopy

  2020cites this paper
• EMA suspends licence for ingenol mebutate (Picato)

  2020cites this paper
• Randomized Trial of Four Treatment Approaches for Actinic Keratosis

  2019cites this paper
• Reflectance confocal microscopy for noninvasive examination of nonmelanocytic tumors and virus‐associated skin lesions in organ transplant recipients

  2019cites this paper
• Evidence for treatment of epidermal keratinocyte neoplasms

  2019cites this paper
• Treatment of Precancers with Topical Agents

  2019cites this paper
• Cutaneous squamous cell carcinoma with incomplete margins demonstrate higher tumour grade on re‐excision

  2019cites this paper
• Chemical Peels

  2019cites this paper
• Review of Clinical Evidence over 10 Years on Prevention and Treatment of a Film-Forming Medical Device Containing Photolyase in the Management of Field Cancerization in Actinic Keratosis

  2019cites this paper
• Assessment of BCL-2 expression in actinic keratosis, keratoacanthoma and seborrheic keratosis cases

  2019cites this paper
• Progression pathways of squamous cell carcinoma associated with actinic damage: from cancer field to actinic keratosis and invasive squamous cell carcinoma

  2019cites this paper
• Prevalence of Actinic Keratosis and Its Associated Risk Factors in Elderly Latvian People

  2018cites this paper
• In‐clinic application of ingenol mebutate 0.015% gel for actinic keratosis in large areas of the face is feasible and attracts a high rate of patient satisfaction: Results of a questionnaire

  2018cites this paper
• Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects*

  2018cites this paper
• Non-invasive treatment of epidermal keratinocyte neoplasms

  2018cites this paper
• Treatment of facial actinic keratoses with a cream containing octatrienoic acid: a multicenter clinical experience.

  2018cites this paper
• Photodynamic Therapy and Skin Cancer

  2018cites this paper
• Treatment of Grade II and III Actinic Keratosis Lesions with a Film-Forming Medical Device Containing Sunscreen/Piroxicam 0.8% and a Retinoic Acid/Glycolic Gel: A Pilot Trial

  2018cites this paper
• Merkel cell carcinoma: Do Australians have a more aggressive variant and a worse outcome?

  2018cites this paper
• Non-invasive treatment of epidermal keratinocyte neoplasms

  2018cites this paper
• Field Cancerization Therapies for Management of Actinic Keratosis: A Narrative Review

  2018cites this paper
• Randomized clinical trial testing the efficacy and safety of 0.5% colchicine cream versus photodynamic therapy with methyl aminolevulinate in the treatment of skin field cancerization: study protocol

  2018cites this paper
• Cryotherapy for Common Premalignant and Malignant Skin Disorders

  2018cites this paper
• Tratamiento de las reacciones cutáneas locales secundarias a ingenol mebutato

  2017cites this paper
• Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients

  2017cites this paper
• Terapia fotodinámica con luz de día en el tratamiento de la queratosis actínica y el campo de cancerización: recomendaciones de consenso para América Latina

  2017cites this paper
• Patient satisfaction and reported outcomes on the management of actinic keratosis

  2017cites this paper
• Histological examination confirms clinical clearance of actinic keratoses following treatment with ingenol mebutate 0·05% gel

  2017cites this paper
• A Novel Actinic Keratosis Field Assessment Scale for Grading Actinic Keratosis Disease Severity.

  2017cites this paper
• The cost-effectiveness of 5-FU-SA in the treatment of actinic keratoses of the face and scalp in the UK secondary care setting

  2017cites this paper
• Cyclooxygenase in Cancer Prevention and Treatments for Actinic Keratosis

  2017influential citation
• Efficacy of a film-forming medical device containing sunscreen (50+) and piroxicam 0.8% in actinic keratosis and field cancerization: a multicenter, assessor-blinded, 3 month trial

  2017cites this paper
• FACULDADE DE MEDICINA DA UNIVERSIDADE DE COIMBRA MESTRADO INTEGRADO EM MEDICINA – TRABALHO FINAL

  2017cites this paper
• Actinic keratosis‐related signs predictive of squamous cell carcinoma in renal transplant recipients: a nested case–control study

  2017cites this paper
• New and current preventive treatment options in actinic keratosis

  2017cites this paper
• Bactericidal Effect of Photodynamic Therapy, Alone or in Combination with Mupirocin or Linezolid, on Staphylococcus aureus

  2017cites this paper
• AN OVERVIEW OF CURRENT AND NOVEL TREATMENT APPROACHES FOR ACTINIC KERATOSIS

  2017influential citation
• Spanish version of the Actinic Keratosis Quality of Life questionnaire

  2017cites this paper
• Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma

  2016cites this paper
• Real-life efficacy and safety of ingenol mebutate for the treatment of actinic keratosis of the face and scalp: A single arm retrospective study

  2016cites this paper
• Ablative fractional laser improves treatment of actinic keratoses with Ingenol Mebutate

  2016cites this paper
• The ratio of non‐hyperkeratotic and hyperkeratotic actinic keratosis in a high‐risk non‐melanoma skin cancer cohort in Queensland

  2016cites this paper
• New Topical Treatment Options for Actinic Keratosis: A Systematic Review.

  2016cites this paper
• Clinical protocol standardized in a public health system using a prototype for actinic keratosis and field cancerization treatment

  2016cites this paper
• The continued use of sunscreen prevents the development of actinic keratosis in aged Japanese subjects

  2016cites this paper
• Thickness of Actinic Keratosis Does Not Predict Dysplasia Severity or P53 Expression

  2016cites this paper
• Common benign skin lesions

  2016cites this paper
• Recommendations for managing cutaneous disorders associated with advancing age

  2016cites this paper
• Actinic keratosis: a cross‐sectional study of disease characteristics and treatment patterns in Danish dermatology clinics

  2016cites this paper
• Molecular Modeling Studies of Some Uracil and New Deoxyuridine Derivatives

  2016cites this paper
• The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument

  2016cites this paper
• Facial cutaneous squamous cell carcinoma

  2016cites this paper
• Actinic keratosis: correlation between clinical and histological classification systems

  2016cites this paper
• Italian expert consensus for the management of actinic keratosis in immunocompetent patients

  2016cites this paper
• In vivo confocal microscopy efficacy assessment of daylight photodynamic therapy in actinic keratosis patients

  2016cites this paper
• Management of local skin reactions after the application of ingenol mebutate gel for the treatment of actinic keratosis: four illustrative cases

  2016cites this paper
• In-office Painless Aminolevulinic Acid Photodynamic Therapy: A Proof of Concept Study and Clinical Experience in More Than 100 Patients.

  2016cites this paper
• A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ.

  2016cites this paper
• Adherence to topical therapies in actinic keratosis: A literature review

  2016cites this paper
• Differences in Disease-specific Quality of Life in Patients with Actinic Keratosis in Australia and Denmark.

  2016cites this paper
• Ablative fractional laser intensifies treatment outcome of scalp actinic keratoses with ingenol mebutate: a case report

  2016cites this paper
• Comparison of morphologic criteria for actinic keratosis and squamous cell carcinoma using in vivo multiphoton tomography

  2016cites this paper
• Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study

  2016cites this paper
• How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling

  2016cites this paper
• Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain

  2016cites this paper
• Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.

  2016cites this paper
• Efficacy, Safety, and Tolerability of 4% 5-Fluorouracil Cream in a Novel Patented Aqueous Cream Containing Peanut Oil Once Daily Compared With 5% 5-Fluorouracil Cream Twice Daily: Meeting the Challenge in the Treatment of Actinic Keratosis.

  2016cites this paper
• Laser-mediated Photodynamic Therapy: An Alternative Treatment for Actinic Keratosis?

  2016cites this paper
• Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.

  2016cites this paper
• Interventions for the pain of topical photodynamic therapy

  2015cites this paper
• A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosis

  2015cites this paper
• Dealing with common skin lesions in older people

  2015cites this paper
• Rapidly‐growing squamous cell carcinoma shortly after treatment with ingenol mebutate for actinic keratoses: report of two cases

  2015cites this paper
• Non-melanoma Skin Cancer in Canada Chapter 1: Introduction to the Guidelines

  2015cites this paper
• Monitoring treatment of field cancerisation with 3% diclofenac sodium 2.5% hyaluronic acid by reflectance confocal microscopy: a histologic correlation.

  2015cites this paper
• Histopathological analysis of the therapeutic response to cryotherapy with liquid nitrogen in patients with multiple actinic keratosis*

  2015cites this paper
• Skin cancer for dental professionals

  2015cites this paper
• High‐definition optical coherence tomography algorithm for the discrimination of actinic keratosis from normal skin and from squamous cell carcinoma

  2015cites this paper
• Patient Perception of Imiquimod Treatment for Actinic Keratosis and Superficial Basal Cell Carcinoma in 202 Patients

  2015cites this paper
• Primary Care Review of Actinic Keratosis and Its Therapeutic Options: A Global Perspective

  2015cites this paper